Independent photoelectric artificial retina device and method of using same

• US 5,397,350 A
• Filed: 05/03/1993
• Issued: 03/14/1995
• Est. Priority Date: 05/03/1993
• Status: Expired due to Term

• Current Assignee: IMI Intelligent Medical Implants AG (Pixium Vision SA)
• Original Assignee: Alan Y. Chow
• Inventors: Chow, Alan Y., Chow, Vincent
• Primary Examiner(s): Green, Randall L.
• Assistant Examiner(s): JONES, MARYBETH O
• Application Number:
  US08/056,672
• Time in Patent Office: 680 Days
• Field of Search: 607/115, 607/116, 607/53, 607/54, 128/898, 623/4, 623/24, 623/66
• US Class Current: 623/6.63
• CPC Class Codes: A61F 9/00727 Apparatus for retinal reattachment
• CPC Class Codes: A61F 9/08 Devices or methods enabling eye-patients to replace direct visual perception by another kind of perception
• CPC Class Codes: A61N 1/0543 Retinal electrodes
• CPC Class Codes: A61N 1/36046 of the eye
• CPC Class Codes: H01L 27/14643 Photodiode arrays; MOS imagers

Abstract

Microscopic photoelectric devices with semitransparent surface electrodes are combined with a liquid or other suitable vehicle. Together they are injected into the subretinal space of the eye. The microscopic photoelectric devices transduce incident light into electric current that will stimulate the overlying cellular layers of the retina. In persons suffering from visual disfunction due to outer retinal layer damage, such devices may allow useful formed artificial vision. The preferred independent surface electrode microphotodiodes (ISEMCP'"'"'s) may be in the shape of microspheres, microdiscs or other microshapes. The ISEMCP'"'"'s are formed of either PiN or NiP type semiconductors, or a combination of both, in a single unit. These devices will form a dipole when exposed to light due to the electric current generated. A magnetic field applied in the vicinity of the eye may help align the ISEMCP'"'"'s within the retina so that their photo-active surfaces face the incident light. Alternatively, the ISEMCP'"'"'s may be embedded and prealigned in a transparent flexible sheet, permeable to nutrients and oxygen, before implantation into the subretinal space. Such sheet will allow passage of biological nutrients and oxygen around the ISEMCP'"'"'s. This sheet may also dissolve leaving behind ISEMCP units lying separately, or in an arranged pattern produced by a surrounding mesh.

Claims

1. A method of producing artificially formed vision in an eye, comprising the step of introducing a plurality of physically separate microscopic photoelectric devices into the subretinal space of the eye, wherein each of said devices ranges in size from about 0.1 to 1000 microns.

2. The method defined in claim 1, wherein said plurality of discrete microscopic photoelectric devices comprise discrete microphotodiodes.

3. The method defined in claim 2, wherein said plurality of discrete microphotodiodes comprise P-i-N semiconductors.

4. The method defined in claim 2, wherein said plurality of discrete microphotodiodes comprise N-i-P semiconductors.

5. The method defined in claim 2, further comprising the step of aligning the microphotodiodes to receive light incident upon the eye.

6. The method defined in claim 5, wherein the microphotodiodes are aligned with a magnetic field.

15. The method defined in claim 5, further comprising the steps of injecting a liquid that is non-miscible in water over the posterior pole in the vitreous cavity after the suspension is injected to aid in the settling of the retina, and then removing the non-miscible liquid after the retina is settled.

16. The method defined in claim 15, wherein the non-miscible liquid comprises perfluorocarbon.

7. A method of producing formed vision in an eye comprising the steps of suspending a plurality of discrete microphotodiodes in a liquid, and injecting the suspension into the subretinal space of the eye, wherein at least some of the injected microphotodiodes are oriented to receive light.

8. The method defined in claim 7, wherein the plurality of microphotodiodes are introduced by a canula into the vitreous cavity for implantation into the subretinal space.

9. The method defined in claim 8, wherein the plurality of microphotodiodes are introduced into the vitreous cavity by creation of a pars plana incision.

10. The method defined in claim 9, wherein the posterior vitreous is dissected to separate the posterior hyaloid face from the retinal surface, and an incision is made through the retina.

11. The method defined in claim 10, wherein the subretinal space is entered with a small retinotomy incision along the direction of the nerve fiber layer, followed by dissection of the inner retina from the outer retina.

12. The method defined in claim 7, wherein the liquid comprises a balanced salt solution.

13. The method defined in claim 7, wherein the liquid comprises a viscous agent.

14. The method defined in claim 11, wherein the viscous agent comprises methylcellulose.

17. A surgical technique for producing artificial vision comprising the steps of:

providing a pars plana incision into the eye;

providing posterior hyaloid separation of the vitreous;

creating a retinotomy opening into the retina;

dissecting and separating the retina;

suspending individual sterile microphotodiodes in an injectable vehicle; and

injecting the individual sterile microphotodiodes into the subretinal space.

18. A surgical technique for producing artificial vision comprising the steps of:

providing a pars plana incision into the eye;

providing posterior hyaloid separation of the vitreous;

creating a retinotomy opening into the retina;

dissecting and separating the retina;

embedding individual sterile microphotodiodes in a sheet wherein the sheet comprises oxygen and nutrient permeable material; and

implanting the microphotodiode-impregnated oxygen and nutrient permeable material into the subretinal space.